Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Poly(l-val)
2. Polyvaline
1. 516-06-3
2. 2-amino-3-methylbutanoic Acid
3. H-dl-val-oh
4. Valine, Dl-
5. 2-aminoisovaleric Acid
6. Fema No. 3444
7. Nsc 9755
8. Mfcd00004267
9. 2-amino-3-methylbutanoic Acid, Dl-
10. 25609-85-2
11. Valina
12. Dl-.alpha.-aminoisovaleric Acid
13. Chebi:27266
14. 4ca13a832h
15. Nsc-9755
16. Nsc76038
17. Valin
18. L-valine-13c5,15n
19. Poly-l-valine
20. Dl-2-amino-3-methylbutanoic Acid
21. 2-aminoisovaleric Acid, Dl-
22. Laevo-valine
23. Hval
24. Unii-4ca13a832h
25. Ccris 8604
26. L-(+)-.alpha.-aminoisovaleric Acid
27. Mfcd00064219
28. Mfcd00064220
29. Nsc-20654
30. Alpha-aminoisovaleric Acid, Dl-
31. (dl)-valine
32. Dextro,laevo-valine
33. 1116448-82-8
34. (rs)-valine
35. Einecs 208-220-0
36. 2-amino-3-methylbutyric Acid, Dl-
37. Dl-val
38. D-valine-[d8]
39. D,l-valine
40. Ai3-18308
41. Dl-2-aminoisovaleric Acid
42. Dl-valine, >=97%
43. Schembl8515
44. Valine, (l)
45. D,l-valine [fhfi]
46. Val-376
47. Wln: Qvyzy1&1
48. Dl-valine-[2,3-d2]
49. 2-amino-3-methylbutanoicacid
50. Chembl11257
51. Wln: Qvyzy1&1 -d
52. Wln: Qvyzy1&1 -l
53. (+/-)-a-aminoisovaleric Acid
54. (+/-)-valine
55. Dtxsid70859522
56. Nsc9755
57. Dl-valine, >=97% (tlc)
58. 202407-30-5
59. Bcp30283
60. Nsc20654
61. Lmfa01100046
62. Nsc125673
63. Nsc125674
64. Stl194272
65. Akos000118926
66. Akos016050509
67. Ab02568
68. Ab02570
69. Am82364
70. Cs-w013605
71. Hy-w012889
72. Nsc-125673
73. Nsc-125674
74. (+/-)-2-aminoisovaleric Acid
75. Ncgc00159470-03
76. Ac-24062
77. As-11670
78. Sy002589
79. Sy002593
80. 2-amino-3-methylbutanoic Acid (dl-valine)
81. Dl-valine, Vetec(tm) Reagent Grade, 99%
82. Ft-0625531
83. Ft-0625632
84. Ft-0628054
85. Ft-0675760
86. Ft-0698111
87. V0013
88. (+/-)-2-amino-3-methylbutyric Acid
89. 5-methylisoxazole-3-carboxylic Acid Ethyl Ester
90. Dl-valine, Reagentplus(r), >=99.0% (nt)
91. 516v063
92. Sr-01000944852
93. Q-100577
94. Sr-01000944852-1
95. Q27109943
96. Z57127382
97. F2191-0220
98. Valine; Nsc 76038; Nsc-76038; Nsc76038; Valina
99. 8d785241-1ac3-4c14-8d43-308a8ea5169c
| Molecular Weight | 117.15 g/mol |
|---|---|
| Molecular Formula | C5H11NO2 |
| XLogP3 | -2.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 117.078978594 g/mol |
| Monoisotopic Mass | 117.078978594 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 90.4 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A DL-Valine API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DL-Valine API, including repackagers and relabelers. The FDA regulates DL-Valine API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DL-Valine API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DL-Valine API manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DL-Valine API supplier is an individual or a company that provides DL-Valine API active pharmaceutical ingredient (API) or DL-Valine API finished formulations upon request. The DL-Valine API suppliers may include DL-Valine API API manufacturers, exporters, distributors and traders.
click here to find a list of DL-Valine API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DL-Valine API DMF (Drug Master File) is a document detailing the whole manufacturing process of DL-Valine API active pharmaceutical ingredient (API) in detail. Different forms of DL-Valine API DMFs exist exist since differing nations have different regulations, such as DL-Valine API USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DL-Valine API DMF submitted to regulatory agencies in the US is known as a USDMF. DL-Valine API USDMF includes data on DL-Valine API's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DL-Valine API USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DL-Valine API suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DL-Valine API Drug Master File in Japan (DL-Valine API JDMF) empowers DL-Valine API API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DL-Valine API JDMF during the approval evaluation for pharmaceutical products. At the time of DL-Valine API JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DL-Valine API suppliers with JDMF on PharmaCompass.
DL-Valine API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DL-Valine API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DL-Valine API GMP manufacturer or DL-Valine API GMP API supplier for your needs.
A DL-Valine API CoA (Certificate of Analysis) is a formal document that attests to DL-Valine API's compliance with DL-Valine API specifications and serves as a tool for batch-level quality control.
DL-Valine API CoA mostly includes findings from lab analyses of a specific batch. For each DL-Valine API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DL-Valine API may be tested according to a variety of international standards, such as European Pharmacopoeia (DL-Valine API EP), DL-Valine API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DL-Valine API USP).
LOOKING FOR A SUPPLIER?
